AVI BioPharma announced this week that it has expanded its management team with the addition of two new vice presidents.
The company said that it has named Peter O’Hanley as its senior vice president of clinical development and regulatory affairs, and Ray Cummings as vice president of business development.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.